Recently, a robust, real time, label-free SPR biomarker detection platform for ICAM-1(+) nEVs was developed for predicting the existence and stage of coronary heart disease (CHD) (Hosseinkhani et al., 2017). This evidence concerns the gene ICAM1 and coronary artery disorder.